Patient Welfare Implications of Indication-Specific Value-Based Pricing of Multi-Indication Drugs.

Jiang, Yawen; Li, Meng; Jiang, Shan; Si, Lei; Gu, Yuanyuan

Jiang, Yawen; Li, Meng; Jiang, Shan; Si, Lei; Gu, Yuanyuan.

Afiliação

Jiang Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China. Electronic address: jiangyw26@mail.sysu.edu.cn.
Li M; The Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, Boston, MA.
Jiang S; Macquarie University Centre for the Health Economy, Macquarie University, Sydney, NSW, Australia.
Si L; School of Health Sciences, Western Sydney University, Campbelltown, NSW, Australia; Translational Health Research Institute, Western Sydney University, Penrith, NSW, Australia.
Gu Y; Macquarie University Centre for the Health Economy, Macquarie University, Sydney, NSW, Australia. Electronic address: yuanyuan.gu@mq.edu.au.

Value Health ; 27(3): 273-277, 2024 Mar.

Article em En | MEDLINE | ID: mdl-38042332

Assuntos

Custos de Medicamentos; Seguridade Social; Humanos; Custos e Análise de Custo; Incerteza

Palavras-chave

indication-based; pharmaceutical; pricing; value-based; welfare

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Estado_mercado_regulacao / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Seguridade Social / Custos de Medicamentos Limite: Humans Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google